MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Magnetic resonance imaging(MRI)"

  • 2018 International Congress

    MRI volumetrics in parkinsonian syndromes

    K. Ma, A. Chan, L. Shi, J. Abrigo, T. Cheung, C. Lau, V. Mok (Hong Kong, Hong Kong)

    Objective: We aimed to explore the ability of MRI volumetrics by using an automated segmentation software called Accubrain in differentiating (1) between different parkinsonian syndromes…
  • 2018 International Congress

    Longitudinal decline in white matter integrity in Parkinson’s disease: An analysis of Parkinson Progression Markers Initiative diffusion tensor imaging data

    K. Taylor, F. Sambataro, A. Bertolino, J. Dukart (Basel, Switzerland)

    Objective: To determine the relative changes in white matter integrity as measured by diffusion tensor imaging (DTI) magnetic resonance imaging (MRI) in PD patients relative…
  • 2018 International Congress

    Longitudinal MRI to predict cognitive impairment in Parkinson’s disease

    T. Melzer, D. Myall, L. Livingston, M. Almuqbel, M. MacAskill, T. Pitcher, K. Horne, S. Grenfell, M. Pascoe, D. Miller, R. Keenan, J. Dalrymple-Alford, T. Anderson (Christchurch, New Zealand)

    Objective: To determine the value of MRI metrics in predicting global cognitive ability in Parkinson’s disease (PD). Background: Progressive cognitive impairment is a dominant feature…
  • 2018 International Congress

    Neuromelanin-MRI in REM sleep behaviour disorder predicts dopaminergic dysfunction and clinical risk of Parkinson’s disease

    T. Barber, L. Griffanti, K. Bradley, D. McGowan, M. Crabbe, C. Lo, C. Mackay, J. Klein, M. Hu (Oxford, United Kingdom)

    Objective: To determine whether neuromelanin-MRI signal changes in the substantia nigra and locus coeruleus in patients with REM sleep behaviour disorder (RBD) are predictive of…
  • 2018 International Congress

    Spatial correlation and segregation of multimodal MRI abnormalities in multiple system atrophy

    J.H. Lee, M.J. Lee, T.H. Kim (Yangsan-si, Gyeongsangnam-do, Republic of Korea)

    Objective: This study aimed to quantify spatial patterns of multimodal MRI abnormalities in basal ganglia (BG) and brainstem-cerebellar (Stem-CB) regions and define structural MRI findings…
  • 2018 International Congress

    Quantitative analysis of DaT uptake and neuromelanin MR contrast in patients with Parkinson’s disease and healthy controls

    D. Ben Bashat, M. Artzi, A. Mirelman, T. Thaler, A. Orr Urterger, M. Weisz, E. Even-Sapir, K. Evans, R. Hutchison, J. Cedarbaum, H. Lerman Shacham (Tel Aviv, Israel)

    Objective: To examined quantitative measures of neuromelanin (NM) MRI and DaT-SPECT imaging of the SN and striatum to distinguish PD patients from healthy control subjects…
  • 2018 International Congress

    Feasibility aspects of evaluating neuroplastic changes after balance training in Parkinson´s disease: A pilot randomised controlled trial

    H. Johansson, M. Hagströmer, U. Ekman, B. Leavy, M. Freidle, E. Schalling, P. Svenningsson, E. Franzén (Huddinge, Sweden)

    Objective: The aim of this pilot study was to explore trial design and to assess feasibility and acceptability of the data collection methods and the…
  • 2018 International Congress

    Effects of non-invasive brain stimulation on motor-speech disorders in Parkinson’s disease

    I. Rektorova, P. Klobusiakova, L. Brabenec, J. Mekyska, Z. Galaz, M. Kostalova (Brno, Czech Republic)

    Objective: To investigate acute effects of repetitive transcranial magnetic stimulation (rTMS) of the motor and auditory feedback area on hypokinetic dysarthria in Parkinson’s disease (PD)…
  • 2018 International Congress

    Diffusion magnetic resonance imaging for predicting the severity of Progressive supranuclear palsy

    X.A. Zhao, S.H. Lin, C.C. Tsai, Y.M. Wu, W.Y. Lin, Y.H. Weng, L.S. Lu, Y.L. Chen, J.J. Wang (Taoyuan City, Taiwan)

    Objective: The current study proposed to build a prediction model of clinical severity from the combination of multiple diffusion tensor derived indices in patients with…
  • 2018 International Congress

    Substantia nigra T1 maps for the diagnosis of Parkinson’s disease

    C. Juri, L. Tapia, J. Cruz, S. Uribe, M. Andia (Santiago, Chile)

    Objective: To evaluate if the T1 value (measured in ms) in the substantia nigra (SN) is reduced in Parkinson disease (PD) patients as compared with…
  • « Previous Page
  • 1
  • …
  • 51
  • 52
  • 53
  • 54
  • 55
  • …
  • 72
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley